Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-07

Clinical Trial Update: Antidandruff Lotion Mediating Microbiome Rebalance [NA]

View source ↗

Summary

A sponsor-L'Oreal clinical trial evaluating an antidandruff lotion intended to rebalance the scalp microbiome in dandruff patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antidandruff Lotion Mediating Microbiome Rebalance

Snippet

Sponsor: L'Oreal | Conditions: Dandruff | NA | Status: RECRUITING